FDA Grants Orphan, Rare Pediatric Status To NEU-001 For Hirschsprung
04 Mar 2025 //
BUSINESSWIRE
Neurenati Therapeutics: Board Strengthening with Dr. Cohard-Radice
08 May 2024 //
BUSINESSWIRE
Neurenati Therapeutics Raises $1.7M In Second Seed Funding Round
18 Apr 2024 //
BUSINESSWIRE
Neurenati Therapeutics Concludes a 1.2 Million $ Seed Financing Round
29 Feb 2024 //
BUSINESSWIRE